• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Early Net Ultrafiltration during Continuous Renal Replacement Therapy: Impact of Admission Diagnosis and Association with Mortality.持续肾脏替代治疗期间的早期净超滤:入院诊断的影响及其与死亡率的关联
Blood Purif. 2024;53(3):170-180. doi: 10.1159/000535315. Epub 2023 Nov 22.
2
Determinants of Urine Output Using Advanced Hemodynamic Monitoring in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy.使用先进的血流动力学监测在接受连续肾脏替代治疗的危重症患者中确定尿量的决定因素。
Blood Purif. 2024;53(3):189-199. doi: 10.1159/000535544. Epub 2023 Dec 16.
3
Intensity of continuous renal replacement therapy for acute kidney injury.急性肾损伤的持续肾脏替代治疗强度
Cochrane Database Syst Rev. 2016 Oct 4;10(10):CD010613. doi: 10.1002/14651858.CD010613.pub2.
4
Reduction Rate of Uric Acid in Blood during Continuous Renal Replacement Therapy for Acute Kidney Injury: A Multicenter Retrospective Observational Study.急性肾损伤持续肾脏替代治疗期间血尿酸的降低率:一项多中心回顾性观察研究
Blood Purif. 2025;54(2):83-92. doi: 10.1159/000542329. Epub 2024 Oct 29.
5
The role of a "volume sparing" strategy in kidney replacement therapy of AKI: a retrospective single-center study.“容量节约”策略在急性肾损伤肾脏替代治疗中的作用:一项回顾性单中心研究。
J Nephrol. 2025 Jan;38(1):235-241. doi: 10.1007/s40620-024-02142-z. Epub 2025 Jan 9.
6
Hepcidin Removal during Continuous Renal Replacement Therapy.连续性肾脏替代治疗期间铁调素的清除。
Blood Purif. 2024;53(1):23-29. doi: 10.1159/000534297. Epub 2023 Nov 3.
7
The Clearance of Midazolam and Metabolites during Continuous Renal Replacement Therapy in Critically Ill Patients with COVID-19.COVID-19 危重症患者连续性肾脏替代治疗期间咪达唑仑及其代谢物的清除率。
Blood Purif. 2024;53(2):107-113. doi: 10.1159/000534538. Epub 2023 Nov 3.
8
Non-pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.非药物干预措施预防连续性肾脏替代治疗中体外循环凝血。
Cochrane Database Syst Rev. 2021 Sep 14;9(9):CD013330. doi: 10.1002/14651858.CD013330.pub2.
9
Association between Net Ultrafiltration Rate and Renal Recovery among Critically Ill Adults with Acute Kidney Injury Receiving Continuous Renal Replacement Therapy: An Observational Cohort Study.接受持续肾脏替代治疗的急性肾损伤成年危重症患者的净超滤率与肾脏恢复之间的关联:一项观察性队列研究
Blood Purif. 2022;51(5):397-409. doi: 10.1159/000517281. Epub 2021 Jul 21.
10
Heliox for croup in children.氦氧混合气治疗儿童喉炎。
Cochrane Database Syst Rev. 2021 Aug 16;8(8):CD006822. doi: 10.1002/14651858.CD006822.pub6.

引用本文的文献

1
Saline flushing to prevent circuit clotting during CRRT without anticoagulant: a randomized controlled study.无抗凝剂连续性肾脏替代治疗(CRRT)期间生理盐水冲洗预防管路凝血的随机对照研究。
BMC Nurs. 2025 Aug 25;24(1):1109. doi: 10.1186/s12912-025-03762-x.
2
The prognostic impact of net ultrafiltration intensity in critically ill patients receiving continuous renal replacement therapy: a multivariable and propensity-matched analysis.接受持续肾脏替代治疗的重症患者净超滤强度的预后影响:多变量及倾向评分匹配分析
Ren Fail. 2025 Dec;47(1):2537810. doi: 10.1080/0886022X.2025.2537810. Epub 2025 Jul 29.
3
Fluid Overload in Children Following Hematopoietic Cell Transplant: A Comprehensive Review.造血干细胞移植后儿童的液体超负荷:一项综合综述。
J Clin Med. 2024 Oct 23;13(21):6348. doi: 10.3390/jcm13216348.

本文引用的文献

1
The relationship between commencement of continuous renal replacement therapy and urine output, fluid balance, mean arterial pressure and vasopressor dose.持续肾脏替代治疗的开始与尿量、液体平衡、平均动脉压及血管升压药剂量之间的关系。
Crit Care Resusc. 2023 Oct 18;24(3):259-267. doi: 10.51893/2022.3.OA5. eCollection 2022 Sep 5.
2
Early restrictive fluid balance is associated with lower hospital mortality independent of acute disease severity in critically ill patients on CRRT.在接受 CRRT 的危重症患者中,早期限制液体平衡与急性疾病严重程度无关,与较低的住院死亡率相关。
Sci Rep. 2021 Sep 14;11(1):18216. doi: 10.1038/s41598-021-97888-y.
3
Association between Net Ultrafiltration Rate and Renal Recovery among Critically Ill Adults with Acute Kidney Injury Receiving Continuous Renal Replacement Therapy: An Observational Cohort Study.接受持续肾脏替代治疗的急性肾损伤成年危重症患者的净超滤率与肾脏恢复之间的关联:一项观察性队列研究
Blood Purif. 2022;51(5):397-409. doi: 10.1159/000517281. Epub 2021 Jul 21.
4
Continuous Renal Replacement Therapy: The Interaction between Fluid Balance and Net Ultrafiltration.连续性肾脏替代治疗:液体平衡与净超滤之间的相互作用
Am J Respir Crit Care Med. 2021 May 1;203(9):1199-1201. doi: 10.1164/rccm.202011-4097LE.
5
Net ultrafiltration prescription survey in Europe.欧洲网络超滤处方调查。
BMC Nephrol. 2020 Dec 1;21(1):522. doi: 10.1186/s12882-020-02184-y.
6
Mediators of the Impact of Hourly Net Ultrafiltration Rate on Mortality in Critically Ill Patients Receiving Continuous Renal Replacement Therapy.小时净超滤率对连续性肾脏替代治疗危重症患者死亡率影响的中介因素。
Crit Care Med. 2020 Oct;48(10):e934-e942. doi: 10.1097/CCM.0000000000004508.
7
Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury.急性肾损伤中肾脏替代治疗的启动时机。
N Engl J Med. 2020 Jul 16;383(3):240-251. doi: 10.1056/NEJMoa2000741.
8
Early net ultrafiltration rate and mortality in critically ill patients receiving continuous renal replacement therapy.接受连续性肾脏替代治疗的危重症患者的早期净超滤率与死亡率
Nephrol Dial Transplant. 2021 May 27;36(6):1112-1119. doi: 10.1093/ndt/gfaa032.
9
Net Ultrafiltration Prescription and Practice Among Critically Ill Patients Receiving Renal Replacement Therapy: A Multinational Survey of Critical Care Practitioners.接受肾脏替代治疗的危重症患者的网络超滤液处方和实践:危重病护理从业者的跨国调查。
Crit Care Med. 2020 Feb;48(2):e87-e97. doi: 10.1097/CCM.0000000000004092.
10
Hourly Fluid Balance in Patients Receiving Continuous Renal Replacement Therapy.连续肾脏替代治疗患者的每小时液体平衡。
Blood Purif. 2020;49(1-2):93-101. doi: 10.1159/000503771. Epub 2019 Dec 17.

持续肾脏替代治疗期间的早期净超滤:入院诊断的影响及其与死亡率的关联

Early Net Ultrafiltration during Continuous Renal Replacement Therapy: Impact of Admission Diagnosis and Association with Mortality.

作者信息

Sansom Benjamin, Udy Andrew, Presneill Jeffrey, Bellomo Rinaldo

机构信息

Department of Intensive Care, The Royal Melbourne Hospital, Melbourne, Victoria, Australia,

Department of Critical Care, The University of Melbourne, Melbourne, Victoria, Australia,

出版信息

Blood Purif. 2024;53(3):170-180. doi: 10.1159/000535315. Epub 2023 Nov 22.

DOI:10.1159/000535315
PMID:37992695
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10911164/
Abstract

INTRODUCTION

Continuous renal replacement therapy (CRRT) is common in the intensive care unit (ICU) but a high net ultrafiltration rate (UFNET) calculated with daily data may increase mortality. We aimed to study early UFNET practice using minute-by-minute CRRT machine recordings and to assess its association with admission diagnosis and mortality.

METHODS

We studied CRRT treatments in three adult ICUs over 7 years. We calculated early UFNET rates minute-by-minute and categorized UFNET into tertiles of mean UFNET in the first 72 h and admission diagnosis. We applied Cox-proportional hazards modelling with censoring of patients who died within 72 h.

RESULTS

We studied 1,218 patients, 154,712 h, and 9,282,729 min of CRRT (5,702 circuits). Mean early UFNET was 1.52 (1.46-1.57) mL/kg/h. Early UFNET tertiles were similar to, but somewhat higher than, previously reported values at 0.00-1.20 mL/kg/h, 1.21-1.93 mL/kg/h, and >1.93 mL/kg/h. UFNET values were similar whether evaluated at 24 or 72 h or for the entire duration of CRRT. There was, however, significant variation in UFNET practice by admission diagnosis: higher in respiratory diseases (pneumonia p = 0.01, other p < 0.0001) and cardiovascular disease (p = 0.005) but lower in cardiothoracic surgery (p = 0.04), renal (p = 0.0003) and toxicology-associated diagnoses (p = 0.01). Higher UFNET was associated with an increased hazard of death, HR 1.24 (1.13-1.37), independent of admission diagnosis, weight, age, sex, presence of end-stage kidney disease, and severity of illness.

CONCLUSION

Early UFNET practice varies significantly by admission diagnosis. Higher early UFNET is independently associated with mortality. Impacts of UFNET on mortality may vary by admission diagnosis. Further work is required to elucidate the nature and mechanisms responsible for this association.

摘要

引言

连续性肾脏替代治疗(CRRT)在重症监护病房(ICU)中很常见,但根据每日数据计算得出的高净超滤率(UFNET)可能会增加死亡率。我们旨在利用CRRT机器逐分钟记录来研究早期UFNET的实践情况,并评估其与入院诊断及死亡率的关联。

方法

我们对三个成人ICU中7年期间的CRRT治疗进行了研究。我们逐分钟计算早期UFNET率,并将UFNET按照前72小时的平均UFNET三分位数以及入院诊断进行分类。对于在72小时内死亡的患者,我们采用Cox比例风险模型进行分析。

结果

我们研究了1218例患者,共154712小时以及9282729分钟的CRRT治疗(5702个治疗回路)。早期平均UFNET为1.52(1.46 - 1.57)毫升/千克/小时。早期UFNET三分位数与先前报道的值相似,但略高,分别为0.00 - 1.20毫升/千克/小时、1.21 - 1.93毫升/千克/小时和>1.93毫升/千克/小时。无论在24小时、72小时还是整个CRRT治疗期间进行评估,UFNET值都相似。然而,根据入院诊断,UFNET的实践存在显著差异:在呼吸系统疾病(肺炎p = 0.01,其他p < 0.0001)和心血管疾病(p = 0.005)中较高,但在心胸外科手术(p = 0.04)、肾脏疾病(p = 0.0003)和毒理学相关诊断(p = 0.01)中较低。较高的UFNET与死亡风险增加相关,风险比为1.24(1.13 - 1.37),独立于入院诊断、体重、年龄、性别、终末期肾病的存在以及疾病严重程度。

结论

早期UFNET的实践因入院诊断而异。较高的早期UFNET与死亡率独立相关。UFNET对死亡率的影响可能因入院诊断而异。需要进一步开展工作以阐明这种关联的性质和机制。